EN DE
Watch Xoma AB B for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

Xoma AB B (XOM-B) fair value: what the stock is really worth

As of Nov 17, 2026: fair value (intrinsic value) of Xoma AB B stock SEK 0.38, price SEK 0.65, that is 42.4% below the price, quality 40 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive SE

XA Xoma AB B logo Thin data Nov 17, 2026

Xoma AB B

XOM-B · ST

Far too expensive (fair value 42% below the price) and weak company, but rising price: meets 1 of 3 rules.

Follow free in the weekly email
Rising price (uptrend) 
Quality 40/100 
Fair value kr 0.3765 · Strongly overvalued 
Weak Growth (revenue YoY −99.9 %/yr in SEK) 
Negative free cash flow 
Trails peers (1/7) 
Narrow moat 6/100 · thin data
Thin data 
⟳ CyclicalEstimate
Watch Xoma AB B for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 2.68 kr 0.2230 Fair Value kr 0.3765 Nov 2024 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.

How to read this chart

24‑month range kr 0.2230 – kr 2.68 · fair‑value band kr 0.2824 – kr 0.4706 · the kr 0.6540 price screens above the kr 0.3765 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.

Follow Xoma AB B in your weekly email

Every Wednesday you see whether Xoma AB B is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Xoma AB (publ) develops and sells algae cultivation and water purification solutions for food security, cosmetics, and pharmaceutical industries. Its principal products are CLAS (closed-loop aquaculture system) and FLOW (filtration of liquids and organic waste).

Show moreShow less

The company was incorporated in 2016 and is headquartered in Gothenburg, Sweden.

Stock analysis

Xoma AB B (XOM-B) currently trades at kr 0.6540, while our estimate is kr 0.3765, 42% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: kr 0.2824 (bear) to kr 0.4706 (bull), the price of kr 0.6540 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 40/100 (below-average quality), in the Consumer Defensive sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Xoma AB B reported revenue of 0 SEK in FY2025 versus 0 SEK in FY2022. Reported net income was −9.6M SEK in FY2025.

Key figures

Market cap 69.3M SEK (≈ $6.8M) Micro · P/S ratio 84.7 · EPS (TTM) kr −0.1200 · Return on equity −111% · Return on assets (EBIT) −65.4% (4-year average) · Operating margin −45,061% · Revenue (TTM) 844K SEK · Revenue growth (YoY) +726%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 6 out of 100 (low confidence).

What moves the price

The share trades about 41% below its 52-week high and 193% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at 10% fair-value upside, at −42%, XOM-B screens richer than that median.

Fair Value

Bear kr 0.2824 Fair Value kr 0.3765 Bull kr 0.4706
Price kr 0.6540 · Downside -42.4%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 40/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 4
How much profit the company makes from its sales and capital
Quality Growth 50
Are margins and returns getting better?
Cashflow 28
Do the profits arrive as real cash?
Financial strength 100
Debt, balance sheet and risk of trouble
Investment 0
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Price momentum 71
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 75
Distance to the 52-week high, does not count
New shares 40
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

XOM-B screens overvalued: fair value 42% below the price. Compare with Muyuan Foods Group →

Compare Xoma AB B with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Farm Products · 298 stocks

Beats the industry median on 1/6 measures
Overall it trails its industry peers.
Valuation
Quality Score 40 · Below median
Fair Value upside −42.4% · Bottom 25%
Profitability
Return on assets −55.8% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 726.0% · Top 25%

Valuation Multiplesvs Farm Products median · lower = cheaper

P/B 4.38× · Priciest 25%
P/S (12 months) 82.14× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 26
FUTURE (revenue growth)100 · sector 22
PAST (return on equity)0 · sector 17
HEALTH (low debt)0 · sector 94
DIVIDEND (yield)0 · sector 42

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Farm Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Charoen Pokphand Foods Public Company CPF 19.55 THB 41.23 THB +111% vs XOM-B
Tyson Foods, Inc TSN $64.25 $91.17 +42% vs XOM-B
Mowi ASA MOWI kr 226.00 kr 274.71 +22% vs XOM-B
Muyuan Foods Group 002714 ¥44.45 ¥53.02 +19% vs XOM-B
United Plantations Berhad 2089 31.64 MYR 34.69 MYR +10% vs XOM-B
Archer-Daniels-Midland Company ADM $67.78 $61.55 −9% vs XOM-B
Wens Foodstuff Group 300498 ¥17.54 ¥12.08 −31% vs XOM-B
Fujian Wanchen Food Group 300972 ¥132.31 ¥88.62 −33% vs XOM-B
Bunge Global SA BG $93.19 $61.59 −34% vs XOM-B
SalMar ASA SALM kr 587.50 kr 260.28 −56% vs XOM-B

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Xoma AB B: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Xoma AB B Fair Value". https://www.fairvalue-calculator.com/stock/XOM-B

Frequently asked questions

Is Xoma AB B (XOM-B) overvalued or undervalued?
As of Nov 17, 2026, our estimate of fair value is kr 0.3765 versus a price of kr 0.6540, about 42% lower (overvalued).
What is the fair value of XOM-B?
Our estimate for Xoma AB B is kr 0.3765 (as of Nov 17, 2026), built from audited fundamentals. The current price: kr 0.6540.
What is the quality score of XOM-B?
Xoma AB B has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Xoma AB B (XOM-B)?
We do not set a price target; the yardstick is our estimate of kr 0.3765 (as of Nov 17, 2026). Cautious scenario kr 0.2824, optimistic scenario kr 0.4706. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Xoma AB B stock forecast for 2026?
Our estimate puts fair value at kr 0.3765, about 42% lower versus a price of kr 0.6540 (overvalued). Cautious scenario kr 0.2824, optimistic scenario kr 0.4706. The calculation is refreshed regularly with new filings.
What is the revenue of Xoma AB B (XOM-B)?
Xoma AB B reported trailing-twelve-month revenue of about 844K SEK (latest available figure, as of Nov 17, 2026).
What is the intrinsic value of Xoma AB B (XOM-B)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Xoma AB B it is kr 0.3765 per share (as of Nov 17, 2026), against a price of kr 0.6540.
Is Xoma AB B stock overvalued or undervalued in 2026?
As of Nov 17, 2026, XOM-B trades above its calculated fair value: price kr 0.6540, fair value kr 0.3765, a gap of about −42% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of XOM-B?
No. The price is what the market pays today (kr 0.6540); the fair value is what the company's own numbers justify (kr 0.3765). For Xoma AB B the two are kr 0.2775 per share apart. That gap is exactly why we show both numbers side by side.
How much is Xoma AB B worth?
The market values Xoma AB B at about 69.3M SEK (market capitalisation, as of Nov 17, 2026). Per share that is kr 0.6540; our models calculate a fair value of kr 0.3765 per share.
What do the bullish and bearish scenarios say about XOM-B?
Our models span a range for Xoma AB B: cautious scenario kr 0.2824, base kr 0.3765, optimistic kr 0.4706 per share (as of Nov 17, 2026, price kr 0.6540). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Xoma AB B (XOM-B)?
Balance-sheet figures for Xoma AB B (as of Nov 17, 2026): return on equity −110.9%. They feed the Quality Score of 40/100, which measures business quality independently of the share price.
How far is XOM-B from its 52-week high?
Xoma AB B trades at kr 0.6540, about 41% below its 52-week high of kr 1.10 and 193% above the low of kr 0.2230 (as of Nov 17, 2026). Distance from the high says nothing about value: that is what the fair value of kr 0.3765 is for.
Which stocks are comparable to Xoma AB B?
From the same area (Consumer Defensive) we also value Muyuan Foods Group, Archer-Daniels-Midland Company, Tyson Foods, Inc, Bunge Global SA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Xoma AB B stock attractive at the current price?
The data as of Nov 17, 2026: price kr 0.6540, calculated fair value kr 0.3765 (−42%), Quality Score 40/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 12.0% above its aggregate fair value. Xoma AB B itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Xoma AB B (XOM-B)?
The closing price on Nov 17, 2026 was kr 0.6540. Our estimate is kr 0.3765, about 42% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Xoma AB B right now?
The price sits above even our optimistic bull case (kr 0.4706). The favourable scenario is already priced in. Weak quality (40/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Xoma AB B

How large is the market capitalisation of Xoma AB B (XOM-B)?
The market capitalisation of Xoma AB B is 69.3M SEK (≈ $6.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Xoma AB B (XOM-B)?
The price-to-sales ratio of Xoma AB B is 84.7 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Xoma AB B (XOM-B)?
Earnings per share at Xoma AB B are kr −0.1200. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Xoma AB B (XOM-B)?
The return on equity (ROE) of Xoma AB B is −111% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Xoma AB B (XOM-B)?
On an EBIT basis the return on assets of Xoma AB B is −65.4% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Xoma AB B (XOM-B)?
The operating margin of Xoma AB B is −45,061% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Xoma AB B (XOM-B)?
Revenue at Xoma AB B is growing 726% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Xoma AB B (XOM-B) generate?
The free cash flow of Xoma AB B is −10.5M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch Xoma AB B in the live analysis

One click puts Xoma AB B on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.